Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Korro Bio, Inc. (KRRO) Institutional Ownership & Insider Trading

107 institutions reported holding Korro Bio, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 45 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

KRROKorro Bio, Inc.Follow KRRO — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
176.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

107 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +17.9%.

Increased+47New+17Decreased-18Closed-7

Largest moves, shares (millions)

Nantahala Capital Management+0.7MBlackRock+0.4MAdage Capital Partners Gp+0.3MAtlas Venture Life Science…-0.2MJane Street Group-0.1MBalyasny Asset Management-0.1M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+1.0Dec 24+0.3Mar 25-0.7Jun 25+0.9Sep 25-2.1Dec 25+5.2Mar 26+2.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2610715+17.9%4717187
Mar 269813+74.4%31252012
Dec 25828-21.5%23192128
Sep 258910+10.0%2723205
Jun 25689-6.7%259914
Mar 257510+2.9%2192217
Dec 24849+11.8%3218128
Sep 24719+0.5%1912145

Korro Bio, Inc. — questions

Who owns Korro Bio, Inc. stock?
107 institutions reported Korro Bio, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Lynx1 Capital Management LP (10.4%), Nantahala Capital Management, LLC (9.0%), NEA Management Company, LLC (8.8%).
Are Korro Bio, Inc. insiders buying or selling?
45 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Korro Bio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.